NfL predicts relapse-free progression in a longitudinal multiple sclerosis cohort study

Background: Easily accessible biomarkers enabling the identification of those patients with multiple sclerosis (MS) who will accumulate irreversible disability in the long term are essential to guide early therapeutic decisions. We here examine the utility of serum neurofilament light chain (sNfL) f...

詳細記述

書誌詳細

主要な著者:	Timo Uphaus, Falk Steffen, Muthuraman Muthuraman, Nina Ripfel, Vinzenz Fleischer, Sergiu Groppa, Tobias Ruck, Sven G. Meuth, Refik Pul, Christoph Kleinschnitz, Erik Ellwardt, Julia Loos, Sinah Engel, Frauke Zipp, Stefan Bittner
フォーマット:	Artigo
言語:	Inglês
出版事項:	Elsevier 2021-10-01
シリーズ:	EBioMedicine
主題:	Multiple sclerosis Disease progression Neurofilament light chain SPMS transition
オンライン･アクセス:	http://www.sciencedirect.com/science/article/pii/S2352396421003832
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!